SlideShare una empresa de Scribd logo
1 de 10
Descargar para leer sin conexión
Science For A Better Life


Science For A Better Life




Investor Conference Call
Q2 2011 Results
Marijn Dekkers, CEO | July 28, 2011

Q1 2011 Investor Conference Call
       • Marijn Dekkers
Q1 2011 Investor Conference Call • Marijn Dekkers • Page 2
Q1 2011 Investor Conference Call • Marijn Dekkers • Page 3
Q1 2011 Investor Conference Call • Marijn Dekkers • Page 4
In € million, % yoy Fx adjusted

              Q2 2011 Group sales by region
                                                                               +5%
      USA                                                         Emerging
      +4%                                                        Economies¹   ~1,300
                    20%                             36%             +7%

                                                                                                  +4%

                                                                                                  ~900

                                                                                                                    +9%
                                                                                                                                      +14%
                                                                                                                    ~600

                  34%                                                                                                                  ~500
                                                  10%
Western Europe                                               Others²
+6%                                                           +2%


                     Group €9,252m; +5%


                                                                              ¹ Emerging economies include: Latin America, Asia w/o Japan, Australia,
Q1 2011 Investor Conference Call • Marijn Dekkers • Page 5                      New Zealand, Africa and Middle East incl. Turkey, Eastern Europe
                                                                              ² Others = Japan, Australia, New Zealand, Canada
                                                                              ³ Emerging Asia = Asia minus Japan, Australia, New Zealand
Q1 2011 Investor Conference Call • Marijn Dekkers • Page 6
Q1 2011 Investor Conference Call • Marijn Dekkers • Page 7
Q1 2011 Investor Conference Call • Marijn Dekkers • Page 8
Fiscal 2011 –
Guidance By Subgroup
Outlook based on Fx and portfolio adj. sales and EBITDA pre-special items

                                                             Unchanged:
HealthCare                                                   Low- to mid-single digit increase of sales and small increase of adj.
                                                             EBITDA


                                                             Unchanged:
Pharma                                                       Low- to mid-single digit increase of sales and improvement of adj.
                                                             EBITDA-margin



                                                             Unchanged:
Consumer Health                                              Mid-single digit growth of sales and adj. EBITDA



                                                             Unchanged:
CropScience                                                  High-single-digit percentage higher sales and growth of adj. EBITDA
                                                             by about 20% - or higher if the season progresses well in 2nd half

                                                             Updated:
                                                             High-single-digit percentage raise of sales. Adj. EBITDA still expected
MaterialScience                                              to increase at a higher rate than sales, although we regard this target
                                                             as increasingly ambitious. Q3’11: Sales and adj. EBITDA in line with
                                                             prior-year level
Q1 2011 Investor Conference Call • Marijn Dekkers • Page 9                                    Outlook depends on specific planning assumptions
                                                                                                          as detailed in the Q2 Quarterly Report
Science For A Better Life




                                                              Investor Conference Call
                                                              Q2 2011 Results
                                                              Marijn Dekkers, CEO | July 28, 2011

Q1 2011 Investor Conference Call • Marijn Dekkers • Page 10

Más contenido relacionado

La actualidad más candente

Highlights of GIC Report 2018/2019
Highlights of GIC Report 2018/2019Highlights of GIC Report 2018/2019
Highlights of GIC Report 2018/2019GIC
 
Lw dissimilar performance of us vs international
Lw dissimilar performance of us vs  internationalLw dissimilar performance of us vs  international
Lw dissimilar performance of us vs internationalBetter Financial Education
 
Summary of GIC Report 2018/2019
Summary of GIC Report 2018/2019Summary of GIC Report 2018/2019
Summary of GIC Report 2018/2019GIC
 
Gilead Sciences: Ladenburg Thalmann financial analyst report January 1997
Gilead Sciences: Ladenburg Thalmann financial analyst report January 1997Gilead Sciences: Ladenburg Thalmann financial analyst report January 1997
Gilead Sciences: Ladenburg Thalmann financial analyst report January 1997MountainHarborGmbH
 
Sarona Frontier Markets Fund
Sarona Frontier Markets FundSarona Frontier Markets Fund
Sarona Frontier Markets Fundlcserge
 
2011 - Q3 - Commentary
2011 - Q3 - Commentary2011 - Q3 - Commentary
2011 - Q3 - CommentaryDrew Beja
 
Dai ichi company profile
Dai ichi company profileDai ichi company profile
Dai ichi company profileKatsukiyo Nishi
 
Greenfield Seitz: Fact Sheet 2015
Greenfield Seitz: Fact Sheet 2015Greenfield Seitz: Fact Sheet 2015
Greenfield Seitz: Fact Sheet 2015stugreenfield
 
Investing Basics
Investing BasicsInvesting Basics
Investing Basicsrbhenderson
 
Highlights of GIC Annual Report 2016/2017
Highlights of GIC Annual Report 2016/2017Highlights of GIC Annual Report 2016/2017
Highlights of GIC Annual Report 2016/2017GIC
 
Q1 2013 Investor Conference Call Presentation Charts
Q1 2013 Investor Conference Call Presentation ChartsQ1 2013 Investor Conference Call Presentation Charts
Q1 2013 Investor Conference Call Presentation ChartsBayer
 
The Power of Dalal street
The Power of Dalal streetThe Power of Dalal street
The Power of Dalal streetSubair NA
 

La actualidad más candente (20)

Highlights of GIC Report 2018/2019
Highlights of GIC Report 2018/2019Highlights of GIC Report 2018/2019
Highlights of GIC Report 2018/2019
 
Lw dissimilar performance of us vs international
Lw dissimilar performance of us vs  internationalLw dissimilar performance of us vs  international
Lw dissimilar performance of us vs international
 
Senate presentation june 2015
Senate presentation june 2015Senate presentation june 2015
Senate presentation june 2015
 
Anchor capital senate group 6th november 2015 - final
Anchor capital   senate group 6th november 2015 - finalAnchor capital   senate group 6th november 2015 - final
Anchor capital senate group 6th november 2015 - final
 
Summary of GIC Report 2018/2019
Summary of GIC Report 2018/2019Summary of GIC Report 2018/2019
Summary of GIC Report 2018/2019
 
Gilead Sciences: Ladenburg Thalmann financial analyst report January 1997
Gilead Sciences: Ladenburg Thalmann financial analyst report January 1997Gilead Sciences: Ladenburg Thalmann financial analyst report January 1997
Gilead Sciences: Ladenburg Thalmann financial analyst report January 1997
 
Sarona Frontier Markets Fund
Sarona Frontier Markets FundSarona Frontier Markets Fund
Sarona Frontier Markets Fund
 
FutureGrowth Asset Management
FutureGrowth Asset ManagementFutureGrowth Asset Management
FutureGrowth Asset Management
 
DSP Equity & Bond Fund
DSP Equity & Bond FundDSP Equity & Bond Fund
DSP Equity & Bond Fund
 
Investec Global Franchise
Investec Global FranchiseInvestec Global Franchise
Investec Global Franchise
 
2011 - Q3 - Commentary
2011 - Q3 - Commentary2011 - Q3 - Commentary
2011 - Q3 - Commentary
 
Dai ichi company profile
Dai ichi company profileDai ichi company profile
Dai ichi company profile
 
Greenfield Seitz: Fact Sheet 2015
Greenfield Seitz: Fact Sheet 2015Greenfield Seitz: Fact Sheet 2015
Greenfield Seitz: Fact Sheet 2015
 
Investec Global Franchise Fund spotlight
Investec Global Franchise Fund spotlightInvestec Global Franchise Fund spotlight
Investec Global Franchise Fund spotlight
 
Investing Basics
Investing BasicsInvesting Basics
Investing Basics
 
Anchor capital
Anchor capitalAnchor capital
Anchor capital
 
Highlights of GIC Annual Report 2016/2017
Highlights of GIC Annual Report 2016/2017Highlights of GIC Annual Report 2016/2017
Highlights of GIC Annual Report 2016/2017
 
Q1 2013 Investor Conference Call Presentation Charts
Q1 2013 Investor Conference Call Presentation ChartsQ1 2013 Investor Conference Call Presentation Charts
Q1 2013 Investor Conference Call Presentation Charts
 
Rules of Thumb
Rules of ThumbRules of Thumb
Rules of Thumb
 
The Power of Dalal street
The Power of Dalal streetThe Power of Dalal street
The Power of Dalal street
 

Similar a Q2 2011 Investor Conference Call Presentation Charts

FY / Q4 2012 Investor Conference Call Presentation
FY / Q4 2012 Investor Conference Call PresentationFY / Q4 2012 Investor Conference Call Presentation
FY / Q4 2012 Investor Conference Call PresentationBayer
 
Bayer AG Q3 2011 Investor Conference Call
Bayer AG Q3 2011 Investor Conference CallBayer AG Q3 2011 Investor Conference Call
Bayer AG Q3 2011 Investor Conference CallBayer
 
Q2 2012 Investor Conference Call Presentation
Q2 2012 Investor Conference Call PresentationQ2 2012 Investor Conference Call Presentation
Q2 2012 Investor Conference Call PresentationBayer
 
Q2 2011 Investor Handout U.S. West Coast Roadshow
Q2 2011 Investor Handout U.S. West Coast RoadshowQ2 2011 Investor Handout U.S. West Coast Roadshow
Q2 2011 Investor Handout U.S. West Coast RoadshowBayer
 
Bayer Investor Presentation Roadshow Frankfurt
Bayer Investor Presentation Roadshow FrankfurtBayer Investor Presentation Roadshow Frankfurt
Bayer Investor Presentation Roadshow FrankfurtBayer
 
FY/Q4 2015 Investor Conference Call Presentation Charts
FY/Q4 2015 Investor Conference Call Presentation ChartsFY/Q4 2015 Investor Conference Call Presentation Charts
FY/Q4 2015 Investor Conference Call Presentation ChartsBayer
 
Q3 2012 Investor Conference Call Presentation
Q3 2012 Investor Conference Call PresentationQ3 2012 Investor Conference Call Presentation
Q3 2012 Investor Conference Call PresentationBayer
 
Q2 2014 Investor Conference Call on 2014-07-30 Presentation Charts
Q2 2014 Investor Conference Call on 2014-07-30 Presentation ChartsQ2 2014 Investor Conference Call on 2014-07-30 Presentation Charts
Q2 2014 Investor Conference Call on 2014-07-30 Presentation ChartsBayer
 
FY / Q4 2011 Investor Conference Call Presentation Charts
FY / Q4 2011 Investor Conference Call Presentation ChartsFY / Q4 2011 Investor Conference Call Presentation Charts
FY / Q4 2011 Investor Conference Call Presentation ChartsBayer
 
FY/Q4 2014 Investor Conference Call Presentation Charts
FY/Q4 2014 Investor Conference Call Presentation ChartsFY/Q4 2014 Investor Conference Call Presentation Charts
FY/Q4 2014 Investor Conference Call Presentation ChartsBayer
 
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...finance34
 
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...finance34
 
Q1 2014 Investtor Conference Call Presentation Charts
Q1 2014 Investtor Conference Call Presentation ChartsQ1 2014 Investtor Conference Call Presentation Charts
Q1 2014 Investtor Conference Call Presentation ChartsBayer
 
Masco Corporation 2012 Fourth Quarter Presentation
Masco Corporation 2012 Fourth Quarter Presentation Masco Corporation 2012 Fourth Quarter Presentation
Masco Corporation 2012 Fourth Quarter Presentation Masco_Investors
 
TenetHealth2002AR
TenetHealth2002ARTenetHealth2002AR
TenetHealth2002ARfinance42
 
FY12 ARI Annual Report
FY12 ARI Annual ReportFY12 ARI Annual Report
FY12 ARI Annual ReportJeff Horn
 
Q3 2014 Investor Conference Call Presentation Charts
Q3 2014 Investor Conference Call Presentation ChartsQ3 2014 Investor Conference Call Presentation Charts
Q3 2014 Investor Conference Call Presentation ChartsBayer
 
McKesson Investor/Analyst Day
	 McKesson Investor/Analyst Day	 McKesson Investor/Analyst Day
McKesson Investor/Analyst Dayfinance2
 
Q2 2015 conference_call_2015-07-29_final_slideshare
Q2 2015 conference_call_2015-07-29_final_slideshareQ2 2015 conference_call_2015-07-29_final_slideshare
Q2 2015 conference_call_2015-07-29_final_slideshareBayer
 
Bayer AG Q3 2010 Investor Handout
Bayer AG Q3 2010 Investor HandoutBayer AG Q3 2010 Investor Handout
Bayer AG Q3 2010 Investor HandoutBayer
 

Similar a Q2 2011 Investor Conference Call Presentation Charts (20)

FY / Q4 2012 Investor Conference Call Presentation
FY / Q4 2012 Investor Conference Call PresentationFY / Q4 2012 Investor Conference Call Presentation
FY / Q4 2012 Investor Conference Call Presentation
 
Bayer AG Q3 2011 Investor Conference Call
Bayer AG Q3 2011 Investor Conference CallBayer AG Q3 2011 Investor Conference Call
Bayer AG Q3 2011 Investor Conference Call
 
Q2 2012 Investor Conference Call Presentation
Q2 2012 Investor Conference Call PresentationQ2 2012 Investor Conference Call Presentation
Q2 2012 Investor Conference Call Presentation
 
Q2 2011 Investor Handout U.S. West Coast Roadshow
Q2 2011 Investor Handout U.S. West Coast RoadshowQ2 2011 Investor Handout U.S. West Coast Roadshow
Q2 2011 Investor Handout U.S. West Coast Roadshow
 
Bayer Investor Presentation Roadshow Frankfurt
Bayer Investor Presentation Roadshow FrankfurtBayer Investor Presentation Roadshow Frankfurt
Bayer Investor Presentation Roadshow Frankfurt
 
FY/Q4 2015 Investor Conference Call Presentation Charts
FY/Q4 2015 Investor Conference Call Presentation ChartsFY/Q4 2015 Investor Conference Call Presentation Charts
FY/Q4 2015 Investor Conference Call Presentation Charts
 
Q3 2012 Investor Conference Call Presentation
Q3 2012 Investor Conference Call PresentationQ3 2012 Investor Conference Call Presentation
Q3 2012 Investor Conference Call Presentation
 
Q2 2014 Investor Conference Call on 2014-07-30 Presentation Charts
Q2 2014 Investor Conference Call on 2014-07-30 Presentation ChartsQ2 2014 Investor Conference Call on 2014-07-30 Presentation Charts
Q2 2014 Investor Conference Call on 2014-07-30 Presentation Charts
 
FY / Q4 2011 Investor Conference Call Presentation Charts
FY / Q4 2011 Investor Conference Call Presentation ChartsFY / Q4 2011 Investor Conference Call Presentation Charts
FY / Q4 2011 Investor Conference Call Presentation Charts
 
FY/Q4 2014 Investor Conference Call Presentation Charts
FY/Q4 2014 Investor Conference Call Presentation ChartsFY/Q4 2014 Investor Conference Call Presentation Charts
FY/Q4 2014 Investor Conference Call Presentation Charts
 
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
 
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
 
Q1 2014 Investtor Conference Call Presentation Charts
Q1 2014 Investtor Conference Call Presentation ChartsQ1 2014 Investtor Conference Call Presentation Charts
Q1 2014 Investtor Conference Call Presentation Charts
 
Masco Corporation 2012 Fourth Quarter Presentation
Masco Corporation 2012 Fourth Quarter Presentation Masco Corporation 2012 Fourth Quarter Presentation
Masco Corporation 2012 Fourth Quarter Presentation
 
TenetHealth2002AR
TenetHealth2002ARTenetHealth2002AR
TenetHealth2002AR
 
FY12 ARI Annual Report
FY12 ARI Annual ReportFY12 ARI Annual Report
FY12 ARI Annual Report
 
Q3 2014 Investor Conference Call Presentation Charts
Q3 2014 Investor Conference Call Presentation ChartsQ3 2014 Investor Conference Call Presentation Charts
Q3 2014 Investor Conference Call Presentation Charts
 
McKesson Investor/Analyst Day
	 McKesson Investor/Analyst Day	 McKesson Investor/Analyst Day
McKesson Investor/Analyst Day
 
Q2 2015 conference_call_2015-07-29_final_slideshare
Q2 2015 conference_call_2015-07-29_final_slideshareQ2 2015 conference_call_2015-07-29_final_slideshare
Q2 2015 conference_call_2015-07-29_final_slideshare
 
Bayer AG Q3 2010 Investor Handout
Bayer AG Q3 2010 Investor HandoutBayer AG Q3 2010 Investor Handout
Bayer AG Q3 2010 Investor Handout
 

Más de Bayer

Q3 2023 Investor Webinar Presentation
Q3 2023 Investor Webinar PresentationQ3 2023 Investor Webinar Presentation
Q3 2023 Investor Webinar PresentationBayer
 
Q2 2023 Investor Webinar Presentation
Q2 2023 Investor Webinar PresentationQ2 2023 Investor Webinar Presentation
Q2 2023 Investor Webinar PresentationBayer
 
Q1 2023 Investor Conference Call Presentation
Q1 2023 Investor Conference Call PresentationQ1 2023 Investor Conference Call Presentation
Q1 2023 Investor Conference Call PresentationBayer
 
Q3 2022 Investor Conference Call Presentation
Q3 2022 Investor Conference Call PresentationQ3 2022 Investor Conference Call Presentation
Q3 2022 Investor Conference Call PresentationBayer
 
Q2 2022 Investor Conference Call Presentation
Q2 2022 Investor Conference Call PresentationQ2 2022 Investor Conference Call Presentation
Q2 2022 Investor Conference Call PresentationBayer
 
Q1 2022 Investor Conference Call Presentation
Q1 2022 Investor Conference Call PresentationQ1 2022 Investor Conference Call Presentation
Q1 2022 Investor Conference Call PresentationBayer
 
FY/Q4 2021 Investor Conference Call Presentation
FY/Q4 2021 Investor Conference Call PresentationFY/Q4 2021 Investor Conference Call Presentation
FY/Q4 2021 Investor Conference Call PresentationBayer
 
Q3 2021 Investor Conference Call Presentation
Q3 2021 Investor Conference Call PresentationQ3 2021 Investor Conference Call Presentation
Q3 2021 Investor Conference Call PresentationBayer
 
Q2 2021 Investor Conference Call Presentation
Q2 2021 Investor Conference Call PresentationQ2 2021 Investor Conference Call Presentation
Q2 2021 Investor Conference Call PresentationBayer
 
Q1 2021 Investor Conference Call Presentation
Q1 2021 Investor Conference Call PresentationQ1 2021 Investor Conference Call Presentation
Q1 2021 Investor Conference Call PresentationBayer
 
FY/Q4 Investor Conference Call Presentation
FY/Q4 Investor Conference Call PresentationFY/Q4 Investor Conference Call Presentation
FY/Q4 Investor Conference Call PresentationBayer
 
Q3 2020 Investor Conference Call Presentation
Q3 2020 Investor Conference Call PresentationQ3 2020 Investor Conference Call Presentation
Q3 2020 Investor Conference Call PresentationBayer
 
Q2 2020 Investor Conference Call Presentation
Q2 2020 Investor Conference Call PresentationQ2 2020 Investor Conference Call Presentation
Q2 2020 Investor Conference Call PresentationBayer
 
Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020
Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020
Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020Bayer
 
FY/Q4 2019 Investor Conference Call Presentation
FY/Q4 2019 Investor Conference Call PresentationFY/Q4 2019 Investor Conference Call Presentation
FY/Q4 2019 Investor Conference Call PresentationBayer
 
Investor Conference Call Presentation: Crop Science R&D Pipeline Update
Investor Conference Call Presentation:  Crop Science R&D Pipeline UpdateInvestor Conference Call Presentation:  Crop Science R&D Pipeline Update
Investor Conference Call Presentation: Crop Science R&D Pipeline UpdateBayer
 
Investor Conference Call Presentation: Bayer 2030 Sustainable Development Ob...
Investor Conference Call Presentation:  Bayer 2030 Sustainable Development Ob...Investor Conference Call Presentation:  Bayer 2030 Sustainable Development Ob...
Investor Conference Call Presentation: Bayer 2030 Sustainable Development Ob...Bayer
 
Q3 2019 Investor Conference Call Presentation
Q3 2019 Investor Conference Call PresentationQ3 2019 Investor Conference Call Presentation
Q3 2019 Investor Conference Call PresentationBayer
 
Crop Science Summer Technology Showcase August 1, 2019
Crop Science Summer Technology Showcase August 1, 2019Crop Science Summer Technology Showcase August 1, 2019
Crop Science Summer Technology Showcase August 1, 2019Bayer
 
Q2 2019 Investor Conference Call Presentation
Q2 2019 Investor Conference Call PresentationQ2 2019 Investor Conference Call Presentation
Q2 2019 Investor Conference Call PresentationBayer
 

Más de Bayer (20)

Q3 2023 Investor Webinar Presentation
Q3 2023 Investor Webinar PresentationQ3 2023 Investor Webinar Presentation
Q3 2023 Investor Webinar Presentation
 
Q2 2023 Investor Webinar Presentation
Q2 2023 Investor Webinar PresentationQ2 2023 Investor Webinar Presentation
Q2 2023 Investor Webinar Presentation
 
Q1 2023 Investor Conference Call Presentation
Q1 2023 Investor Conference Call PresentationQ1 2023 Investor Conference Call Presentation
Q1 2023 Investor Conference Call Presentation
 
Q3 2022 Investor Conference Call Presentation
Q3 2022 Investor Conference Call PresentationQ3 2022 Investor Conference Call Presentation
Q3 2022 Investor Conference Call Presentation
 
Q2 2022 Investor Conference Call Presentation
Q2 2022 Investor Conference Call PresentationQ2 2022 Investor Conference Call Presentation
Q2 2022 Investor Conference Call Presentation
 
Q1 2022 Investor Conference Call Presentation
Q1 2022 Investor Conference Call PresentationQ1 2022 Investor Conference Call Presentation
Q1 2022 Investor Conference Call Presentation
 
FY/Q4 2021 Investor Conference Call Presentation
FY/Q4 2021 Investor Conference Call PresentationFY/Q4 2021 Investor Conference Call Presentation
FY/Q4 2021 Investor Conference Call Presentation
 
Q3 2021 Investor Conference Call Presentation
Q3 2021 Investor Conference Call PresentationQ3 2021 Investor Conference Call Presentation
Q3 2021 Investor Conference Call Presentation
 
Q2 2021 Investor Conference Call Presentation
Q2 2021 Investor Conference Call PresentationQ2 2021 Investor Conference Call Presentation
Q2 2021 Investor Conference Call Presentation
 
Q1 2021 Investor Conference Call Presentation
Q1 2021 Investor Conference Call PresentationQ1 2021 Investor Conference Call Presentation
Q1 2021 Investor Conference Call Presentation
 
FY/Q4 Investor Conference Call Presentation
FY/Q4 Investor Conference Call PresentationFY/Q4 Investor Conference Call Presentation
FY/Q4 Investor Conference Call Presentation
 
Q3 2020 Investor Conference Call Presentation
Q3 2020 Investor Conference Call PresentationQ3 2020 Investor Conference Call Presentation
Q3 2020 Investor Conference Call Presentation
 
Q2 2020 Investor Conference Call Presentation
Q2 2020 Investor Conference Call PresentationQ2 2020 Investor Conference Call Presentation
Q2 2020 Investor Conference Call Presentation
 
Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020
Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020
Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020
 
FY/Q4 2019 Investor Conference Call Presentation
FY/Q4 2019 Investor Conference Call PresentationFY/Q4 2019 Investor Conference Call Presentation
FY/Q4 2019 Investor Conference Call Presentation
 
Investor Conference Call Presentation: Crop Science R&D Pipeline Update
Investor Conference Call Presentation:  Crop Science R&D Pipeline UpdateInvestor Conference Call Presentation:  Crop Science R&D Pipeline Update
Investor Conference Call Presentation: Crop Science R&D Pipeline Update
 
Investor Conference Call Presentation: Bayer 2030 Sustainable Development Ob...
Investor Conference Call Presentation:  Bayer 2030 Sustainable Development Ob...Investor Conference Call Presentation:  Bayer 2030 Sustainable Development Ob...
Investor Conference Call Presentation: Bayer 2030 Sustainable Development Ob...
 
Q3 2019 Investor Conference Call Presentation
Q3 2019 Investor Conference Call PresentationQ3 2019 Investor Conference Call Presentation
Q3 2019 Investor Conference Call Presentation
 
Crop Science Summer Technology Showcase August 1, 2019
Crop Science Summer Technology Showcase August 1, 2019Crop Science Summer Technology Showcase August 1, 2019
Crop Science Summer Technology Showcase August 1, 2019
 
Q2 2019 Investor Conference Call Presentation
Q2 2019 Investor Conference Call PresentationQ2 2019 Investor Conference Call Presentation
Q2 2019 Investor Conference Call Presentation
 

Último

Falcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business PotentialFalcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business PotentialFalcon investment
 
Durg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTS
Durg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTSDurg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTS
Durg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTSkajalroy875762
 
Phases of Negotiation .pptx
 Phases of Negotiation .pptx Phases of Negotiation .pptx
Phases of Negotiation .pptxnandhinijagan9867
 
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur DubaiUAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubaijaehdlyzca
 
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSCROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSpanmisemningshen123
 
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 MonthsSEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 MonthsIndeedSEO
 
Uneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration PresentationUneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration Presentationuneakwhite
 
How to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityHow to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityEric T. Tung
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecZurliaSoop
 
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service AvailableNashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service Availablepr788182
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting
 
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al MizharAl Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizharallensay1
 
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdfDr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdfAdmir Softic
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxCynthia Clay
 
JAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR ESCORTS
JAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR  ESCORTSJAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR  ESCORTS
JAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR ESCORTSkajalroy875762
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGpr788182
 
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAIGetting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAITim Wilson
 
GUWAHATI 💋 Call Girl 9827461493 Call Girls in Escort service book now
GUWAHATI 💋 Call Girl 9827461493 Call Girls in  Escort service book nowGUWAHATI 💋 Call Girl 9827461493 Call Girls in  Escort service book now
GUWAHATI 💋 Call Girl 9827461493 Call Girls in Escort service book nowkapoorjyoti4444
 
Mckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for ViewingMckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for ViewingNauman Safdar
 

Último (20)

Falcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business PotentialFalcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business Potential
 
Durg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTS
Durg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTSDurg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTS
Durg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTS
 
HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024
 
Phases of Negotiation .pptx
 Phases of Negotiation .pptx Phases of Negotiation .pptx
Phases of Negotiation .pptx
 
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur DubaiUAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
 
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSCROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
 
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 MonthsSEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
 
Uneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration PresentationUneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration Presentation
 
How to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityHow to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League City
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
 
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service AvailableNashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investors
 
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al MizharAl Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
 
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdfDr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptx
 
JAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR ESCORTS
JAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR  ESCORTSJAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR  ESCORTS
JAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR ESCORTS
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAIGetting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
 
GUWAHATI 💋 Call Girl 9827461493 Call Girls in Escort service book now
GUWAHATI 💋 Call Girl 9827461493 Call Girls in  Escort service book nowGUWAHATI 💋 Call Girl 9827461493 Call Girls in  Escort service book now
GUWAHATI 💋 Call Girl 9827461493 Call Girls in Escort service book now
 
Mckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for ViewingMckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for Viewing
 

Q2 2011 Investor Conference Call Presentation Charts

  • 1. Science For A Better Life Science For A Better Life Investor Conference Call Q2 2011 Results Marijn Dekkers, CEO | July 28, 2011 Q1 2011 Investor Conference Call • Marijn Dekkers
  • 2. Q1 2011 Investor Conference Call • Marijn Dekkers • Page 2
  • 3. Q1 2011 Investor Conference Call • Marijn Dekkers • Page 3
  • 4. Q1 2011 Investor Conference Call • Marijn Dekkers • Page 4
  • 5. In € million, % yoy Fx adjusted Q2 2011 Group sales by region +5% USA Emerging +4% Economies¹ ~1,300 20% 36% +7% +4% ~900 +9% +14% ~600 34% ~500 10% Western Europe Others² +6% +2% Group €9,252m; +5% ¹ Emerging economies include: Latin America, Asia w/o Japan, Australia, Q1 2011 Investor Conference Call • Marijn Dekkers • Page 5 New Zealand, Africa and Middle East incl. Turkey, Eastern Europe ² Others = Japan, Australia, New Zealand, Canada ³ Emerging Asia = Asia minus Japan, Australia, New Zealand
  • 6. Q1 2011 Investor Conference Call • Marijn Dekkers • Page 6
  • 7. Q1 2011 Investor Conference Call • Marijn Dekkers • Page 7
  • 8. Q1 2011 Investor Conference Call • Marijn Dekkers • Page 8
  • 9. Fiscal 2011 – Guidance By Subgroup Outlook based on Fx and portfolio adj. sales and EBITDA pre-special items Unchanged: HealthCare Low- to mid-single digit increase of sales and small increase of adj. EBITDA Unchanged: Pharma Low- to mid-single digit increase of sales and improvement of adj. EBITDA-margin Unchanged: Consumer Health Mid-single digit growth of sales and adj. EBITDA Unchanged: CropScience High-single-digit percentage higher sales and growth of adj. EBITDA by about 20% - or higher if the season progresses well in 2nd half Updated: High-single-digit percentage raise of sales. Adj. EBITDA still expected MaterialScience to increase at a higher rate than sales, although we regard this target as increasingly ambitious. Q3’11: Sales and adj. EBITDA in line with prior-year level Q1 2011 Investor Conference Call • Marijn Dekkers • Page 9 Outlook depends on specific planning assumptions as detailed in the Q2 Quarterly Report
  • 10. Science For A Better Life Investor Conference Call Q2 2011 Results Marijn Dekkers, CEO | July 28, 2011 Q1 2011 Investor Conference Call • Marijn Dekkers • Page 10